stocktools
Offerings // enGene Therapeutics Inc.

ENGNW offering history

Every offering-related filing in enGene Therapeutics Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 259 filings back to Jun 14, 2023.

Last executed offering
Mar 9, 2026
424B5 — priced deal (shares or notes)
Last registration (announced)
Feb 19, 2026
S-3 — capacity, not a sale
Executed, last 12 months
4
424B pricings + 8-K 3.02 sales
Registered, last 12 months
1
S-1/S-3/F-series registrations
DateFilingWhat it means
Mar 9, 2026424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Mar 2, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Feb 19, 2026S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Jan 21, 20268-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Nov 14, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Nov 12, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Dec 20, 2024424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Nov 21, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Nov 21, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Nov 21, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Nov 21, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Nov 13, 2024S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Nov 13, 2024S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Oct 28, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Oct 25, 20248-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Oct 21, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Sep 26, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Sep 10, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Jul 24, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Jun 14, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
May 15, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Apr 25, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Mar 12, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Mar 5, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Mar 5, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Feb 27, 2024S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Feb 14, 20248-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Dec 28, 20238-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Dec 15, 2023S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Nov 22, 2023S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Oct 31, 20238-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Oct 2, 2023424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Sep 29, 2023EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
ENGNW offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full ENGNW workspace →
ENGNW offering FAQ

When did ENGNW last execute an offering?

Per SEC filings, enGene Therapeutics Inc.'s most recent priced offering document is a 424B5 filed 2026-03-09. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did ENGNW last announce or register an offering?

The most recent registration is a S-3 filed 2026-02-19. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.